<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Structural Biology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/01D0BC96-5DB5-47A2-86A4-1EA6E7A0901F"><gtr:id>01D0BC96-5DB5-47A2-86A4-1EA6E7A0901F</gtr:id><gtr:firstName>Alexandru</gtr:firstName><gtr:otherNames>Radu</gtr:otherNames><gtr:surname>Aricescu</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700232"><gtr:id>F8D5BCC7-68FC-43A5-A510-8717BD7C3083</gtr:id><gtr:title>The Structural Biology of Memory</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0700232</gtr:grantReference><gtr:abstractText>We are interested in understanding the molecular mechanisms responsible for acquisition and storage of information in the brain, i.e. learning and memory. Research over the past five decades led to the idea that activity-dependent changes in the strength of synapses between nerve cells (synaptic plasticity) can represent a mechanism for information storage. The neurotransmitters glutamate and ?-amino-butyric acid (GABA) mediate most synaptic signalling in the vertebrate central nervous system. Their receptors play important roles in the induction, expression and/or modulation of synaptic plasticity. Dysfunction of these molecular systems appears to be responsible for the cognitive decline linked to the ?normal? aging process. From a medical point of view, a wide spectrum of disorders including Alzheimer?s, Parkinson?s, schizophrenia, bipolar disorder, major clinical depression as well as ischemic neuronal injury are linked to the same receptor molecules.
Our research is currently focused on the structural characterization of glutamate and GABA receptors, our main tool being X-ray crystallography. We aim to understand the molecular mechanisms governing their assembly, function and regulation, and to devise ways of modulating their signalling properties. This work is performed using cells grown in culture and state-of-the-art technology including robots for growing protein crystals and synchrotron-generated X-rays.</gtr:abstractText><gtr:technicalSummary>Synaptic plasticity provides the basis for information storage in the brain. This project combines structural (X-ray crystallography) and functional (biochemical, cellular, genetic and electrophysiological) approaches to characterize cell surface receptors important for synaptic transmission and plasticity and, by extension, for learning and memory. Specifically, the key goals are:
(i) to provide atomic level structural information on the glutamate, gamma-amino butyric acid (GABA) and Eph receptors;
(ii) to understand the binding mechanisms and molecular consequences of the interactions within the ephrin/Eph/NMDA receptor complexes;
(iii) to understand the functional significance of various structural elements from the above molecules and their role in signal transduction, in a cellular context.

This project relies on significant technological developments in structural biology, including large-scale expression of constructs derived from cell surface receptors in mammalian cells, nanoliter-scale crystallization and automated plate imaging systems as well as access to the latest generation synchrotron radiation facilities and electron microscopes. In addition, close collaborations with two leading laboratories actively involved in the characterisation of the receptors of interest (Seth Grant at the Wellcome Trust Sanger Institute and Jeff McIlhinney from the MRC Anatomical Neuropharmacology Unit in Oxford) will add an essential functional dimension to complement the structural work and contribute to a comprehensive understanding of these molecular systems.

The glutamate, GABA and Eph receptors have been extensively studied and the body of evidence coming from pharmacology, developmental biology, genetic and behavioural analysis overwhelmingly supports their functional importance. Recent structural results have also contributed significantly to the elucidation of the ligand binding mechanisms (in the case of glutamate receptors) and protein-protein interactions (in the Eph/ephrin signalling system). The major challenge now is to understand the allosteric mechanisms by which individual domains communicate and transduce signals across the plasma membrane, and this is the scientific niche where I hope this project will make a significant contribution.

From the medical point of view, a wide spectrum of disorders including Alzheimer?s, schizophrenia, Parkinson?s and ischemic neuronal injury are linked to cell surface receptors responsible for synaptic plasticity. Dysfunction of the same molecular systems appears to be responsible for the cognitive decline linked to the normal aging process or psychiatric conditions such as bipolar disorder and major clinical depression. Understanding the structure and mechanisms of action of the molecules involved can lead to better therapies and an improved quality of life.</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1014849</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Development of a high-affinity AMPA receptor modulator, targeting the N-terminal domain (NTD)</gtr:description><gtr:id>844721EC-CB1C-4396-AF66-86075E2495AC</gtr:id><gtr:impact>We have successfully applied for joint funding to the MRC Technology (a DGF award).</gtr:impact><gtr:outcomeId>gbj7rg1vYBg-1</gtr:outcomeId><gtr:partnerContribution>The collaborators provided access to technologies not available in my laboratory, such as whole cell and patch clamp electrophysiology.</gtr:partnerContribution><gtr:piContribution>We provided crystallization-grade purified proteins, protein crystals and contributed to surface plasmon resonance experiments.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Anatomical Neuropharmacology Unit</gtr:department><gtr:description>Characterization of a novel binding site in the amino terminal domain of AMPA receptors</gtr:description><gtr:id>07EBCF4E-37C5-4B15-90C3-280F980840DF</gtr:id><gtr:impact>Joint publication: Pubmed ID 19651138</gtr:impact><gtr:outcomeId>A54675F8B11-1</gtr:outcomeId><gtr:partnerContribution>This collaboration is supported by a joint MRC Technology Development Gap Fund grant, which funds a full-time post-doctoral researcher (based in the collaborator's laboratory). This postdoc is performing functional assays on ionotropic glutamate receptors, inspired by our structural work. Their results will feed back information to further refine our experiments.</gtr:partnerContribution><gtr:piContribution>We solved a 1.8A structure of the GluR2 amino-terminal domain, which formed the basis for this grant application and a joint publication (Pubmed ID 19651138).</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Anatomy and Genetics</gtr:department><gtr:description>Ion Channels and Diseases of Electrically Excitable Cells</gtr:description><gtr:id>6602396F-89DD-4DCE-A9D9-EF0E2A0C87D2</gtr:id><gtr:impact>This is very much work in progress. It led to a key publication in the field (Miller &amp;amp; Aricescu, Nature, 2014) and further structural results are expected in the near future.</gtr:impact><gtr:outcomeId>Xjp9uyGWMCc-1</gtr:outcomeId><gtr:partnerContribution>This collaboration resulted in a successful grant application to the Wellcome Trust &amp;quot;&amp;quot;Ion Channels and Diseases of Electrically Excitable Cells&amp;quot; (2008-2013, &amp;pound;6,452,907 Principal applicant Prof FM Ashcroft, on behalf of the OXION consortium, to which my lab belongs). This grant was extended for a further 5 year period, and currently funds a DPhil student in my lab (scholarship and lab expenses).</gtr:partnerContribution><gtr:piContribution>We are actively working on the crystallographyc analysis of several synaptic ion channels; we provide protein samples to clinicians to develop novel diagnostic tools for neurological autoimmune diseases.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press release Coles etal. 2011</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>2FC63109-8A76-447C-A2D6-38EC879A23B3</gtr:id><gtr:impact>A lay audience description of our 2011 Science publication, which reports a pathway with therapeutic implications for regeneration after nerve damage, has been published online with support from the Wellcome Trust media office.

Within days this story has been re-produced on numerous popular science web sites and blogs.</gtr:impact><gtr:outcomeId>USFptsYwgA8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Confidence in Concept Award</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>36BB0C56-E72E-4468-AF7E-A3C4981BFBBD</gtr:id><gtr:outcomeId>p3YiQQDrYhs</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12560</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Research Equipment Grant</gtr:description><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>EEEBF6B8-A40C-40C9-B067-15D836DC81B7</gtr:id><gtr:outcomeId>TdenkJQvDZh0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>147056</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Development Gap Funding</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>63A8E435-8D9B-429B-84C8-9C2C42B59F7D</gtr:id><gtr:outcomeId>89A2450BB3E0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6452907</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Programme Grant</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>4857E92A-AA99-4632-AA08-7D67D68DA560</gtr:id><gtr:outcomeId>HeBYFbLo6Qd0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>106380</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Development Gap Funding</gtr:description><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>8CDF4032-76EA-473B-A93F-518B06C4033F</gtr:id><gtr:outcomeId>iutm3oq21qr0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Disclosed herein are methods of inducing neuronal outgrowth of a neuron. The methods comprise contacting the neuron with an agent that binds receptor protein tyrosine phosphatase sigma (RPTsigma), to thereby induce neuronal outgrowth of the neuron. The agent may induces clustering of RPTPsigma and/or inhibit binding of chondroitin sulfate proteoglycan (CSPG) to RPTPsigma. Examples of suitable agents are heparan sulfate proteoglycan, heparan sulfate, heparan sulfate oligosaccharides, or heparin oligosaccharides. Additional agents are also disclosed. The neuron can be a CNS neuron or peripheral neuron. Also disclosed herein are methods of treating neuronal injury in a subject comprising, administering to the subject an agent that binds RPTPsigma. Administration may be to a site of neuronal injury, to thereby induce neuronal outgrowth at the site of neuronal injury.</gtr:description><gtr:grantRef>G0700232</gtr:grantRef><gtr:id>69536A04-B11C-4547-A3C5-B3B727689451</gtr:id><gtr:impact>- Last author publication in Science (Pubmed ID: 21454754)
- Invited speaker to international meetings (e.g. Proteoglycans Gordon Research Conference)
- Publication highlighted on WT online news and picked up by many online science blogs etc.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>CozHEysPYyb</gtr:outcomeId><gtr:patentId>WO2012112953</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>MOLECULAR SWITCH FOR NEURONAL OUTGROWTH</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A high (1.8A) resolution structure of the human ionotropic glutamate receptor GluR2 amino-terminal domain has been solved, and a putative site of allosteric modulation has been discovered.</gtr:description><gtr:grantRef>G0700232</gtr:grantRef><gtr:id>CB5A44E7-64BB-4DB0-9B70-8BB3203E20B9</gtr:id><gtr:impact>The screening for small molecules able to modulate the receptor function via the newly described site is in progress.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>B84CEE89CF0</gtr:outcomeId><gtr:patentId>WO02060471</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Crystal Structure of the GluR2 amino-terminal domain</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A series of expression vectors for large scale production of recombinant proteins in mammalian cells, for structural studies, has been developed and continues to be expanded. Further aspects related to the whole technology of cell surface receptor production have been established and continue to be optimised.</gtr:description><gtr:id>7130DE0A-EADC-434D-AB42-F45A354D9B27</gtr:id><gtr:impact>Over 200 labs around the world have requested and received these vectors, and advice regarding various aspects of the mammalian expression technology are regularly provided. The paper describing these vectors (Pubmed ID 17001101) has already been cited 56 times so far. Numerous structures of large, glycosylated cell surface receptor constructs obtained using the technology we developed have already been published.</gtr:impact><gtr:outcomeId>6D538D7886B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>pHLsec suite of mammalian expression vectors</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/17001101</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A methodology for automated large scale production of cell surface receptor constructs in mammalian cells has been established, in collaboration with The Automation Partnership. Published in J Struct Biol. (Pubmed ID: 21571074).</gtr:description><gtr:id>553E56DF-AA5C-49AD-AF65-D8E60B6F7851</gtr:id><gtr:impact>This is a technology implemented on a customised large-scale tissue culture robot. Access and training are provided for laboratories around the EU, via the P-Cube programme (funded by EU-FP7). I have organised a heavily oversubscribed workshop (in April 2011) to provide training in novel mammalian expression technologies for high-level recombinant protein expression.</gtr:impact><gtr:outcomeId>EC7D8608747</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>An automated platform for large scale production of recombinant proteins in mammalian cells</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477309/</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5DAD8A48-07E6-4A4E-A504-92A7CA793A0A</gtr:id><gtr:title>Receptor protein tyrosine phosphatase micro: measuring where to stick.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53cd70c2c528ff9abb11a980a68b8eec"><gtr:id>53cd70c2c528ff9abb11a980a68b8eec</gtr:id><gtr:otherNames>Aricescu AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>4BD0B3608BD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D76CA94F-3C8A-428C-B76F-261A62B1D964</gtr:id><gtr:title>Atomic-resolution monitoring of protein maturation in live human cells by NMR.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eafd81fb2fff553b9918a8057b672855"><gtr:id>eafd81fb2fff553b9918a8057b672855</gtr:id><gtr:otherNames>Banci L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>EoxC5Ei4eut</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6CA6FE4-FC1A-450B-B452-C7D407F2311F</gtr:id><gtr:title>Structural insights into hedgehog ligand sequestration by the human hedgehog-interacting protein HHIP.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13fd86e22c120efb853972c740e508f"><gtr:id>b13fd86e22c120efb853972c740e508f</gtr:id><gtr:otherNames>Bishop B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>FF937375AA4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BB48B8E-2470-47E2-8996-1A3AA60D197B</gtr:id><gtr:title>Proteoglycan-specific molecular switch for RPTPs clustering and neuronal extension.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e45552f74935c2b55405cf4aea87bed"><gtr:id>6e45552f74935c2b55405cf4aea87bed</gtr:id><gtr:otherNames>Coles CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>reaxcv4gxDK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1779F26-7E2A-44C8-9A8F-611C6C86B90D</gtr:id><gtr:title>Preparation of recombinant fibronectin fragments for functional and structural studies.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c715d67d12701c5684a7b2782f76edc1"><gtr:id>c715d67d12701c5684a7b2782f76edc1</gtr:id><gtr:otherNames>Staunton D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>BD1AF77BF44</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4531B42A-EC00-46D3-A0BC-6B5E8408AAB2</gtr:id><gtr:title>Ventral closure, headfold fusion and definitive endoderm migration defects in mouse embryos lacking the fibronectin leucine-rich transmembrane protein FLRT3.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45d0302c05231124a3eb35c7c286f9fb"><gtr:id>45d0302c05231124a3eb35c7c286f9fb</gtr:id><gtr:otherNames>Maretto S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>DC41AB7FB7D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B61DEBA3-D7FA-4DFF-B484-CEA8E44CE152</gtr:id><gtr:title>Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5314d785c34e9901a0e5a99a8aff480a"><gtr:id>5314d785c34e9901a0e5a99a8aff480a</gtr:id><gtr:otherNames>Malinauskas T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>r93YEdmpe1X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75DA64D9-9E7E-4409-B0EB-ABFD5EA6E9C4</gtr:id><gtr:title>Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4356eab1246e34581d070464d8892cd2"><gtr:id>4356eab1246e34581d070464d8892cd2</gtr:id><gtr:otherNames>Bowden TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>8E0AFCA5C91</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C421715-436C-4C7A-9C45-193B83BBA8D6</gtr:id><gtr:title>Structural basis for cell surface patterning through NetrinG-NGL interactions.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90d6514d22869015fa3a132781b28749"><gtr:id>90d6514d22869015fa3a132781b28749</gtr:id><gtr:otherNames>Seiradake E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>XAvGqCto1rM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C1FA4C9-B7F2-45A0-B30C-34F2DBCF8213</gtr:id><gtr:title>Transsynaptic Modulation of Kainate Receptor Functions by C1q-like Proteins.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7009bbfefc9c409d00b4692f69aecd7b"><gtr:id>7009bbfefc9c409d00b4692f69aecd7b</gtr:id><gtr:otherNames>Matsuda K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>58c98f1bc84498.56388375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2870B4A6-2399-41C3-BB5B-7CAADF625621</gtr:id><gtr:title>Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4356eab1246e34581d070464d8892cd2"><gtr:id>4356eab1246e34581d070464d8892cd2</gtr:id><gtr:otherNames>Bowden TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>90B159704D5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52496AD2-C285-48C6-89B7-9D6B46C72ED4</gtr:id><gtr:title>Structural basis for extracellular cis and trans RPTPs signal competition in synaptogenesis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e45552f74935c2b55405cf4aea87bed"><gtr:id>6e45552f74935c2b55405cf4aea87bed</gtr:id><gtr:otherNames>Coles CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>doi_55faa1aa1c44d389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0AF0FDC-2113-4406-B59A-ECC09C32EC8F</gtr:id><gtr:title>Crystal structure of the GluR2 amino-terminal domain provides insights into the architecture and assembly of ionotropic glutamate receptors.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94cecf5eee5ee2651ba0267133ed5d73"><gtr:id>94cecf5eee5ee2651ba0267133ed5d73</gtr:id><gtr:otherNames>Clayton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>DB48189E9EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4A00CAC-9126-44AF-B65F-EEB399C37369</gtr:id><gtr:title>Structure of the repulsive guidance molecule (RGM)-neogenin signaling hub.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fb2d21fc56bd01f2d144aaf93abade8"><gtr:id>5fb2d21fc56bd01f2d144aaf93abade8</gtr:id><gtr:otherNames>Bell CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_15205_25_23744777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AADC2E20-4B42-4A81-96D2-40EDB6EDB5BF</gtr:id><gtr:title>Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4356eab1246e34581d070464d8892cd2"><gtr:id>4356eab1246e34581d070464d8892cd2</gtr:id><gtr:otherNames>Bowden TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>pm_15205_25_23025485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC6E45BB-7EEB-429E-ABA2-1BB83880194A</gtr:id><gtr:title>Initiation of T cell signaling by CD45 segregation at 'close contacts'.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68a136b0edbb71d5410f0ee7a4e92009"><gtr:id>68a136b0edbb71d5410f0ee7a4e92009</gtr:id><gtr:otherNames>Chang VT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>585d66aadb7050.86809664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B974FD5-15D4-4897-BAC5-106E901E7666</gtr:id><gtr:title>An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90d6514d22869015fa3a132781b28749"><gtr:id>90d6514d22869015fa3a132781b28749</gtr:id><gtr:otherNames>Seiradake E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>jXe22CULuAf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B636BC0F-1DB8-4EA9-8A66-2843CA001F46</gtr:id><gtr:title>A GluD Coming-Of-Age Story.</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20f4ff1fd6d2822c3ee5220a6e2d8724"><gtr:id>20f4ff1fd6d2822c3ee5220a6e2d8724</gtr:id><gtr:otherNames>Yuzaki M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>58c98f1b8e2cb3.28420938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78644803-FCEB-4D05-944B-9C37F48756F6</gtr:id><gtr:title>Protein tyrosine phosphatases: structure-function relationships.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63f0ecc85e60ba33591dbb9439a878ec"><gtr:id>63f0ecc85e60ba33591dbb9439a878ec</gtr:id><gtr:otherNames>Tabernero L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>5859C102213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EB6F4FA-75EA-4862-8DD5-6D32848EEBDE</gtr:id><gtr:title>Crystal structure of a human GABAA receptor.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d4baceaf0e34aa81cd387370317059"><gtr:id>e5d4baceaf0e34aa81cd387370317059</gtr:id><gtr:otherNames>Miller PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>546116536cd320.64409255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E66DB0A9-DCFF-4B16-81A3-9176E8214F0A</gtr:id><gtr:title>Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18a28d8b9384d80bc97c8f0b04d80ca"><gtr:id>a18a28d8b9384d80bc97c8f0b04d80ca</gtr:id><gtr:otherNames>Crispin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>FC6ADCB5D28</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>311ED6AC-60B2-494A-8535-3257E55D03D6</gtr:id><gtr:title>Automation of large scale transient protein expression in mammalian cells.</gtr:title><gtr:parentPublicationTitle>Journal of structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673680106ade3187f249d2a683028495"><gtr:id>673680106ade3187f249d2a683028495</gtr:id><gtr:otherNames>Zhao Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1047-8477</gtr:issn><gtr:outcomeId>iW2EFLEYna8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DBE7215-B87A-46CF-8604-B9C77CDD52E7</gtr:id><gtr:title>Structural and functional studies of LRP6 ectodomain reveal a platform for Wnt signaling.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1661961c3e118f7f4e3b8856f64cecee"><gtr:id>1661961c3e118f7f4e3b8856f64cecee</gtr:id><gtr:otherNames>Chen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>W25Q1JNeVAs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AD3DAAE-FC8E-4A24-ADDC-6241F7CE5564</gtr:id><gtr:title>Structural basis of semaphorin-plexin signalling.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/886b3e6aa85103d0bc4dce2eeb2374a7"><gtr:id>886b3e6aa85103d0bc4dce2eeb2374a7</gtr:id><gtr:otherNames>Janssen BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a327e0a9c6606.79525453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B813DA96-AE1D-48AC-A57D-A71DF6ACC233</gtr:id><gtr:title>Expression of recombinant glycoproteins in mammalian cells: towards an integrative approach to structural biology.</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53cd70c2c528ff9abb11a980a68b8eec"><gtr:id>53cd70c2c528ff9abb11a980a68b8eec</gtr:id><gtr:otherNames>Aricescu AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn><gtr:outcomeId>pm_15205_25_23623336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF53C07B-5EEA-4C00-8EB1-D59C9A72D531</gtr:id><gtr:title>Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4356eab1246e34581d070464d8892cd2"><gtr:id>4356eab1246e34581d070464d8892cd2</gtr:id><gtr:otherNames>Bowden TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>CCC66E2DC18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C9BC835-D1B3-4EAB-858F-FEB342435FF2</gtr:id><gtr:title>Structural basis for integration of GluD receptors within synaptic organizer complexes.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28a3a0c7eda173905ff4475c995d3ec9"><gtr:id>28a3a0c7eda173905ff4475c995d3ec9</gtr:id><gtr:otherNames>Elegheert J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>585d4fd9a2c388.64215858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78DD4134-E5EC-4CDA-BA47-2992DF5A6C9C</gtr:id><gtr:title>Extracellular regulation of type IIa receptor protein tyrosine phosphatases: mechanistic insights from structural analyses.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e45552f74935c2b55405cf4aea87bed"><gtr:id>6e45552f74935c2b55405cf4aea87bed</gtr:id><gtr:otherNames>Coles CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>54611653a7d8d8.62892570</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50064A2A-C24B-4A2B-9585-AE700E67741D</gtr:id><gtr:title>Structurally encoded intraclass differences in EphA clusters drive distinct cell responses.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90d6514d22869015fa3a132781b28749"><gtr:id>90d6514d22869015fa3a132781b28749</gtr:id><gtr:otherNames>Seiradake E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_15205_25_23812375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8562F158-15EF-4A33-9D8C-76B9C601C2B8</gtr:id><gtr:title>A dual binding mode for RhoGTPases in plexin signalling.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fb2d21fc56bd01f2d144aaf93abade8"><gtr:id>5fb2d21fc56bd01f2d144aaf93abade8</gtr:id><gtr:otherNames>Bell CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>XkmSPX1gzzF</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700232</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>